Dr. Misty T. Sharp, MD

Dr. Sharp practices at Westmoreland Dermatology & Surgery Center, PA in Columbus, Mississippi.

Dr. Sharp's NPI, 1871500231, was assigned on August 1, 2006. Dr. Sharp graduated from University of Arkansas College of Medicine in 2001. Dr. Sharp holds Mississippi license 19576.

Dr. Sharp's primary practice is Westmoreland Dermatology & Surgery Center, PA, at 2110 5th N St, Columbus, MS 39705 in Lowndes County. The practice phone is (662) 243-2435.

Dr. Sharp's primary practice is Westmoreland Dermatology & Surgery Center, PA in Columbus, Mississippi. Dr. Sharp is also affiliated with University Hospitals Cleveland Medical Center. The medical group on file is Westmoreland Dermatology and Surgery Center. Dmand AI also links Dr. Sharp to 2 more hospitals, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sharp practices, 5 sites in all. Vendor and product names are available with a free account.

Dermatopathology is Dr. Sharp's primary specialty in the NPI Registry, under taxonomy code 207ND0900X. Dmand AI has Dr. Sharp's licenses on file in 2 states: Mississippi and Arkansas.

CMS data shows 11,901 Medicare services from Dr. Sharp across 24 procedure codes in 2024, for 2,478 Medicare patients. Medicare paid $491,680 for them. Every service was in an office.

CMS counts 2,478 Medicare patients who saw Dr. Sharp in 2024. The largest group is 75 to 84, with 1,059 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sharp's median patient age at 69, with 55% women.

In 2024, Dr. Sharp wrote 1,136 Medicare Part D claims for 357 patients. 90% of them were for generic drugs. CMS names the drug for 997 of them, across 24 drugs with 11 or more claims each, at $932,202 in total drug cost. In 2023, CMS named 936 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Sharp for performance year 2024, reported individually. Dr. Sharp accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 2,062 procedures of removal of skin lesions by Dr. Sharp, more than 98% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 39 general payments to Dr. Sharp from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Celgene Corporation paid the most, $187.

Dr. Sharp graduated from University of Arkansas College of Medicine in 2001.